ACCTIVATE Study: Improving Telehealth for Diabetes Management

This study, called ACCTIVATE, is looking at ways to help people with diabetes better use telehealth (healthcare services delivered remotely, like video calls). It tests two main approaches: Digital Health Coaching, which helps patients learn digital skills and use telehealth tools, and Practice Facilitation, which supports clinics in addressing differences in telehealth use among patients. The goal is to see if these interventions can improve your diabetes control (measured by A1C, a blood test that shows average blood sugar levels) and how often you use patient portals. You might be able to join if you are 18 or older, speak English or Spanish, have uncontrolled diabetes (A1C of 8.0% or higher), and have visited a participating clinic at least twice in the last two years. The study aims to enroll 600 participants.

Study design
This is an interventional study with a planned enrollment of 600 participants. It is testing two interventions: Digital Health Coaching for patients and Practice Facilitation for clinics.
What's involved
Participants will have their A1C and patient portal use measured at the start of the study, and then again at 3, 6, and 12 months.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 12 months, with measurements taken at 3, 6, and 12 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06598436

Achieving Chronic Care equiTy by leVeraging the Telehealth Ecosystem

Recruiting
NAAges 18+InterventionalHealth services
University of California, San Francisco
~600 participants
Updated 2026-01-06 on ClinicalTrials.gov
What's tested:Digital Health Coaching (Patient-Level Intervention)Practice Facilitation (Clinic-Level Intervention)

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in Patient-Level Hemoglobin A1C
Measured over Baseline, month 3, month 6, and month 12
+1 more outcome measured
Diabetes
1 sites across 1 states
California1
  • Delphine Tuot, MD MAS · PRINCIPAL_INVESTIGATOR · University of California, San Francisco

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

≥ 18 years of age
English or Spanish-Speaking
Have uncontrolled diabetes defined as a listed diagnosis of diabetes with a recorded A1C ≥ 8.0% in the past two years or have uncontrolled HTN defined as a listed diagnosis of HTN and last recorded documented SBP \>140 mmHg
At least 2 visits at a participating SFHN primary care site in the last 24 months

Exclusion

Higher than average digital literacy, defined as an Digital Healthcare Literacy Scale (DHLS) score greater than 10, as determined prior to the baseline study visit; these patients may not benefit from a digital coaching intervention.
Presence of co-morbid conditions that would make it inappropriate to focus on telehealth chronic disease management. Conditions may include: end-stage or terminal condition with limited life expectancy and severe mental illness.
Lack of any working phone number
Visual or hearing impairment that precludes use of telehealth for chronic disease management
Cognitive impairment defined by the inability to restate study goals during the consent process
Pregnant
  • Change in Patient-Level Hemoglobin A1CBaseline, month 3, month 6, and month 12

    Change in A1C (%) will be determined by subtracting month 3, 6, and 12 A1C values from baseline A1C

  • Change in Patient Portal UseBaseline, month 3, month 6, and month 12

    The average number of patient portal log-ins per month will be obtained from the EHR